Live feed
Filing
SC 13G/A
SC 13G/A0001615774-19-002673·Corbus Pharmaceuticals Holdings, Inc.
Schedule 13G ownership disclosure
Corbus Pharmaceuticals Holdings, Inc.
Security class unavailable · CUSIP: 21833P103
Event date: 2019-02-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,501,467
- Percent of class
- 8.6700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001615774-19-002673
- Form type
- SC 13G/A
- Filer
- Corbus Pharmaceuticals Holdings, Inc.
- CIK
- CIK 1595097
- Filed
- Feb 19, 2019
- Reporting period
- Feb 07, 2019
- Description
- Schedule 13G beneficial ownership